Alliances
BioCT becomes first state association to join New England Edge, taking advantage of discounts on lab and office supplies and services
Hundreds of patients at multiple sites throughout China to benefit from electronic informed consent process in landmark investigator-led Schizophrenia trial
Toronto Innovation Acceleration Partners, a leading member-based Canadian provider of venture builder expertise in the early-stage health science field, is pleased to announce the establishment of a collaboration with Amgen, a global leader in the biotechnology industry.
Cyclotron to be dedicated to the production of radiopharmaceuticals for diagnosing and treating critical illnesses worldwide
Genedata Biologics to accelerate antibody discovery and streamline R&D operations at Finland’s largest biopharma company
With immunotherapies playing an ever-increasingly important role in clinical oncology development, Werum IT Solutions and the Blood Centers of America have teamed up to develop a “vein-to-vein” digital supply chain solution suite in order to provide a standardized, scalable and compliant platform for the cell and gene therapy market.
It’s been an incredibly busy week so far for San Francisco-based Atomwise, a company focused on using artificial intelligence (AI) for drug discovery. The company has signed three deals this week and it’s only Wednesday.
The deal had the upside potential of $1.7 billion but showed mixed results in three Phase III clinical trials. Sanofi announced it had terminated the collaboration, but Lexicon lashed out, alleging Sanofi’s termination was “invalid” and the company was “in breach of contract.”
DCprime Initiates Research Collaboration with the University Medical Center of Groningen on Relapse Vaccine Approach for Ovarian Cancer
Secarna Pharmaceuticals announced that the Company has entered into an research agreement with a global pharmaceutical company to support research and discovery in the field of oncology.
PRESS RELEASES